Home > Research > Browse

Results for Drug Administration Schedule

Publications & Outputs

  1. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

    Sandercock, P., Wardlaw, J. M., Lindley, R. I., Dennis, M., Cohen, G., Murray, G., Innes, K., Venables, G., Czlonkowska, A., Kobayashi, A., Ricci, S., Murray, V., Berge, E., Slot, K. B., Hankey, G. J., Correia, M., Peeters, A., Matz, K., Lyrer, P., Gubitz, G., & 4 othersPhillips, S. J., Arauz, A., Emsley, H. & IST-3 collaborative group, 23/06/2012, In: The Lancet. 379, 9834, p. 2352-2363 12 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review